Nisa Investment Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.45K | Buy |
1,038
+302
| +41% | +$2.46K | ﹤0.01% | 2329 |
|
|
2025
Q1 | $5.78K | Buy |
736
+45
| +7% | +$353 | ﹤0.01% | 2218 |
|
|
2024
Q4 | $10.3K | Hold |
691
| – | – | ﹤0.01% | 2127 |
|
|
2024
Q3 | $10.6K | Sell |
691
-103
| -13% | -$1.58K | ﹤0.01% | 2087 |
|
|
2024
Q2 | $12.1K | Buy |
794
+55
| +7% | +$838 | ﹤0.01% | 2091 |
|
|
2024
Q1 | $14K | Buy |
739
+92
| +14% | +$1.74K | ﹤0.01% | 1977 |
|
|
2023
Q4 | $12.4K | Sell |
647
-40
| -6% | -$764 | ﹤0.01% | 1994 |
|
|
2023
Q3 | $12.3K | Buy |
687
+10
| +1% | +$180 | ﹤0.01% | 2133 |
|
|
2023
Q2 | $13.8K | Buy |
677
+335
| +98% | +$6.8K | ﹤0.01% | 2195 |
|
|
2023
Q1 | $6K | Sell |
342
-1,537
| -82% | -$27K | ﹤0.01% | 2226 |
|
|
2022
Q4 | $39K | Sell |
1,879
-25
| -1% | -$519 | ﹤0.01% | 1852 |
|
|
2022
Q3 | $49K | Buy |
1,904
+37
| +2% | +$952 | ﹤0.01% | 1749 |
|
|
2022
Q2 | $47K | Sell |
1,867
-53
| -3% | -$1.33K | ﹤0.01% | 1750 |
|
|
2022
Q1 | $61K | Sell |
1,920
-180
| -9% | -$5.72K | ﹤0.01% | 1780 |
|
|
2021
Q4 | $65K | Sell |
2,100
-350
| -14% | -$10.8K | ﹤0.01% | 1649 |
|
|
2021
Q3 | $85 | Hold |
2,450
| – | – | ﹤0.01% | 1774 |
|
|
2021
Q2 | $67 | Hold |
2,450
| – | – | ﹤0.01% | 1859 |
|
|
2021
Q1 | $69 | Hold |
2,450
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q4 | $64K | Buy |
+2,450
| New | +$64K | ﹤0.01% | 1915 |
|